Oryzon Genomics S.A. ORYZF
Set alert
3.10 USD 0.00 0.00%
At close · Oct 30
3.45 Day range 3.45
3.10 52-week range 3.70
- YTD
- -7.81%
- 1 year
- -14.20%
- Open
- 3.45
- Prev close
- 3.10
- Mkt cap
- 253.86M
- Vol
- 100
- Avg vol
- 709
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 3.45
- High
- 3.45
News
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
- ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
- ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
- ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
- ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease
- ORYZON to Participate in Upcoming Events in November
- ORYZON Receives Feedback From the FDA in Response to the Submitted Phase III Protocol in Borderline Personality Disorder
- ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
Your note
Sign in to keep a note on ORYZF — it syncs with the Stock Master app.